Our Story
CodonRX® was founded with the goal of making high-quality, science-backed health products more affordable and accessible. Our team of experts at NC State developed our proprietary AI (Anti-Inflammatory) formulation to provide targeted relief for chronic digestive symptoms, including diarrhea, bloating, gas, abdominal pain, and constipation.
"Our labs at NC State spent years researching and developing the anti-inflammatory properties of CodonRX. It’s rare for patented research to evolve into a real-world product that enhances quality of life. I’m thrilled to see CodonRX reach the market and hopeful that it will make a meaningful difference in consumer’s health."
What Makes Us Unique
- Patented Formula: Our exclusive AI formulation is protected by patents worldwide, ensuring you receive the most advanced probiotic solution available.
- Scientifically Advanced: CodonRX® products are developed using cutting-edge research and technology, providing effective relief for IBS symptoms.
- Quality Assurance: Manufactured in the USA under stringent conditions, our products are independently tested for potency and purity. CodonRX® probiotics are vegan and allergen-free, containing no gluten, dairy, eggs, soy, shellfish, tree nuts, coconut, peanuts, fish, wheat, sesame seeds, or pesticides.
Our Values
Innovation
We continuously strive to develop new and improved health solutions.
Accessibility
We aim to make our products affordable and accessible to everyone.
Integrity
We uphold the highest standards of quality and transparency in everything we do.
Meet the Team
Kevin White, PhD - Founder and Chairman
Our founder, Dr. Kevin White, has had a career spanning top research institutions—including Stanford, Yale, and the University of Chicago—and in industry as President and Chief Science Officer of Tempus AI, a leader in AI-driven precision medicine, which debuted on Nasdaq in June 2024. Dr. White has pioneered innovative approaches in precision medicine, bringing cutting-edge scientific advancements from the lab to real-world applications.
Andrew Lim, PhD - Chief Operations Officer
Our COO, Dr. Andrew Lim, brings global leadership experience across healthcare, technology and AI, having held executive roles at Genome.One, Garvan Institute and DNAnexus. He’s led commercial operations and strategy, business development, and digital innovation initiatives, with prior roles at Seagate Technology, Telstra, and the Boston Consulting Group. Dr. Lim holds a Ph.D. from UC Berkeley and a B.Sc. (Hons) from the University of Sydney.
Lauren Kan, MSc - Head of Product
Our Head of Product, Lauren Kan, brings over a decade of experience leading data- driven healthcare initiatives. She previously managed precision oncology reporting and product development at Tempus AI and led the informatics efforts for the Chicago Department of Public Health’s COVID-19 response. With a background in bioinformatics and operations, Lauren specializes in building practical, cross-functional solutions that improve patient outcomes and healthcare delivery.
Rodolphe Barrangou, PhD - Chief Scientific Advisor
Dr. Rodolphe Barrangou, Chairman of the CodonRX Scientific Advisory Board, is a global leader in microbiome and CRISPR research. He’s the inventor on the first CRISPR patent, a founder of Intellia Therapeutics (Nasdaq: NTLA), and Chairman of Caribou Biosciences. A former probiotics engineer at DuPont, he is now a Distinguished Professor at NC State, helping shape CodonRX’s scientific direction.